Company intelligence
Koneksa
Koneksa transforms complex multimodal measures to actionable clinical insights for the pharma and biotech industries.
About Koneksa
Koneksa is a measurement-science partner helping clinical development teams generate clearer, earlier, and more decision-ready evidence. By designing measurement strategies grounded in disease biology and therapeutic intent, Koneksa integrates physiological, clinical, and digital signals to reduce variability and clarify treatment effects. Through high-reliability execution and integrated scientific interpretation, Koneksa supports more confident decisions throughout the clinical development lifecycle.
Verified activity
Signals from Koneksa
3 published signals
Research & Knowledge
Koneksa conducted a study involving 80+ participants recording their voice for nine weeks using smartphones to track Parkinson's speech effects.
Reported by Koneksa
Presence & Recognition
Koneksa will host a demo by Mike Mendoza at SCDM 2026 featuring Lodestar™ submission software.
Reported by Koneksa
Research & Knowledge
Koneksa announced positive topline results from KH007, a 12-month study evaluating digital measures of PD progression conducted in curated collaboration with Merck and Regeneron under Koneksa's data syndication model.
Reported by Koneksa